Premium
Bortezomib, lenalidomide and dexamethasone (VRD) combination as salvage therapy in refractory angioimmunoblastic T cell lymphoma
Author(s) -
Chaoui Driss,
Bouallegue Sonia,
Arakelyan Nina,
Genet Philippe,
Aljijakli Ahmad,
Sutton Laurent
Publication year - 2014
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.12678
Subject(s) - angioimmunoblastic t cell lymphoma , bortezomib , lenalidomide , medicine , salvage therapy , transplantation , oncology , multiple myeloma , chemotherapy , immunology , t cell , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom